CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
about
Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virusRespiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses.Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of PlasmodiumInfluenza vaccines based on virus-like particlesVirus-like particles as universal influenza vaccinesImmunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7The lung vascular filter as a site of immune induction for T cell responses to large embolic antigen.Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenzaContribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceB1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.Baculovirus capsid display potentiates OVA cytotoxic and innate immune responses.CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells.Tumor antigen cross-presentation and the dendritic cell: where it all begins?Ebola virus-like particles protect from lethal Ebola virus infection.Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.The role of dendritic cell subsets in selection between tolerance and immunity.Origin, precursors and differentiation of mouse dendritic cells.Dendritic cells as inducers of antimicrobial immunity in vivo.Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantationAging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand.Vaccines that facilitate antigen entry into dendritic cells.Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II.Dendritic cells in viral pathogenesis: protective or defective?Two Distinctive Phenotypes of AcMNPV Display Different Immune Abilities and Intracellular Destiny.A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta.The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.The cross-priming pathway: a portrait of an intricate immune system.Virus-like particles: flexible platforms for vaccine development.Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency.Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice.The cell biology of cross-presentation and the role of dendritic cell subsets.Developments in virus-like particle-based vaccines for infectious diseases and cancer.The use of agonistic anti-CD40 therapy in treatments for cancer.Developments in virus-like particle-based vaccines for HIV.VLPs and particle strategies for cancer vaccines.Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
P2860
Q24564228-D748E283-AF46-4E61-98F7-393D9622E949Q27438122-3CBC4F3D-EFC4-4035-AA23-4156CE150365Q28730541-3188ACF8-43F1-4E34-AB77-C03046A49C9DQ30376236-75C57640-B5A1-4B29-961B-E53318E2DF89Q30421558-E865B114-1CFF-477F-91EB-5A8ED9615CF5Q33569555-61ABC842-510E-4C0D-90AD-764EDACBA028Q33591053-7517159E-CD31-45F1-8322-A64AB3470A5FQ33658250-47522068-986B-4EC9-8361-040250080A4EQ33717736-A876B647-98F3-4B9B-99C8-7A84602A5B02Q33737706-A362B903-F726-4B49-AC46-2EFE3F891C55Q33900378-B443E3E1-C137-4600-8014-04B00921F4B4Q34019812-824E82E6-1D8C-4D7A-A4C8-BB93871D0F20Q34093092-14DD6B06-5256-4568-B12B-5F1C0C353A0AQ34210664-3C72A0BC-1B82-4AEC-A4A0-AB5FE8258181Q34792924-3472B2EF-4CDB-46E1-ABC0-1420F826E83FQ34801021-6D195AA4-95C6-4C58-8DA1-1D208E4FB2B1Q34842295-C70F3401-EEA6-4068-B106-DC2F0F2A6355Q35183165-621E4E20-41ED-4E0E-8223-E8FD1B188011Q35219298-284060CD-E14E-4673-B8DF-E3465901EF44Q35232804-7D243CF9-93BF-452A-A5D5-292B3AE1A490Q35799360-0A229131-5101-458F-BB4A-EC043DCF0328Q35810437-3741B618-1B2F-4472-AD7C-19DE64C66CCFQ35915763-8744208D-2252-4BDF-AE7F-95B5ADAB02A4Q36178572-CD9C2B73-56C7-4EDE-8F47-114FB4112A85Q36207868-C73A8B5A-D662-4A6C-BF51-5108DA41E9B9Q36235817-62B8EAAD-E5D0-4D6C-A4E3-893B0BBF52DCQ36256534-8D69D46B-A5EF-4EEE-AE30-F64C663C4652Q36370726-40B3EAB8-E2C9-43E4-AD37-E10DFAE83891Q36371212-1C449AD8-05BD-4E6A-8F09-CD7666DB56B0Q36770431-44F50695-1431-4015-8FC8-17DC6B38B454Q36837144-433D0D19-13DD-4D8E-B46F-736A88220F24Q36846046-8022B5EF-B9FF-4B46-A4EA-A003DD8BEA05Q36934005-90F2FA58-1146-4298-B15F-B6C15F1EAC90Q36994291-E9817AED-4E17-4715-8707-DD244E1432AAQ37082455-D4BBF60F-83E8-4ED9-AD0F-44F3913BF2F7Q37951525-1FE92380-624F-4A77-9328-CA1D291F3AA6Q38026924-D2C41377-9262-4879-9ED4-B00DFDB2D9E9Q38081965-CDF64F5D-CED2-48D3-9975-119F504247B4Q38152475-3E929B5F-F5A1-4ACB-96F3-4E096BE3B991Q39447177-E2F87BB2-67A0-45FD-B4EC-36A392B9844E
P2860
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@ast
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@en
type
label
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@ast
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@en
prefLabel
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@ast
CD8alpha- CD11b+ dendritic cel ...... CD8alpha and CD205 molecules.
@en
P2093
P2860
P356
P1476
CD8alpha- CD11b+ dendritic cel ...... s CD8alpha and CD205 molecules
@en
P2093
Claude Leclerc
Gabriel Morón
Paloma Rueda
P2860
P304
P356
10.1084/JEM.20011930
P407
P577
2002-05-01T00:00:00Z